PROTEIN-BINDING OF DIGITOXIN, VALPROATE AND PHENYTOIN IN SERA FROM DIABETICS

被引:22
作者
DOUCET, J
FRESEL, J
HUE, G
MOORE, N
机构
[1] HOP BOIS GUILLAUME,CHU ROUEN,DEPT DIABETOL,F-76223 BOIS GUILLAUME,FRANCE
[2] HOP BOIS GUILLAUME,CHU ROUEN,DEPT PHARMACOL,F-76223 BOIS GUILLAUME,FRANCE
[3] HOP BOIS GUILLAUME,CHU ROUEN,DEPT BIOCHEM,F-76223 BOIS GUILLAUME,FRANCE
关键词
PROTEIN BINDING; DIABETES-MELLITUS; DIGITOXIN; INSULIN DEPENDENT; VALPROATE; PHENYTOIN; GLYCATED ALBUMIN;
D O I
10.1007/BF00315318
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Chronic hyperglycaemia results in glycation of serum albumin and might affect the binding of drugs. The aim of the present study was to compare, using an equilibrium dialysis method, the protein binding of therapeutic concentrations digitoxin, valproate and phenytoin in sera from 70 insulin-dependent diabetics and 25 controls. Drug concentrations were measured by fluorescence immunopolarisation. Glycated albumin was measured by laser nephelometry after affinity chromatography. In sera from diabetics, protein binding of digitoxin (88.8 versus 89.9%) was unchanged; the protein binding of valproate (75.2 versus 80.7%) and phenytoin (67.9 versus 75.3%) was significantly decreased, but with no correlation with the concentration of glycated albumin. We conclude that the difference in protein binding between diabetic and control sera is due to glucose-independent modification of albumin in diabetics.
引用
收藏
页码:577 / 579
页数:3
相关论文
共 17 条
[1]   MEASUREMENT OF GLYCOSYLATED AMINO-ACIDS AND PEPTIDES FROM URINE OF DIABETIC-PATIENTS USING AFFINITY-CHROMATOGRAPHY [J].
BROWNLEE, M ;
VLASSARA, H ;
CERAMI, A .
DIABETES, 1980, 29 (12) :1044-1047
[2]  
BUHN HF, 1978, SCIENCE, V200, P21
[3]  
CRAMER JA, 1979, THER DRUG MONIT, V9, P105
[4]  
GARLICK RL, 1983, J BIOL CHEM, V258, P6142
[5]   SERUM-PROTEIN BINDING OF PHENYTOIN AND VALPROIC ACID IN INSULIN-DEPENDENT DIABETES-MELLITUS [J].
GATTI, G ;
CREMA, F ;
ATTARDOPARRINELLO, G ;
FRATINO, P ;
AGUZZI, F ;
PERUCCA, E .
THERAPEUTIC DRUG MONITORING, 1987, 9 (04) :389-391
[6]   THE INFLUENCE OF DISEASE ON PLASMA-PROTEIN BINDING OF DRUGS [J].
GRAINGERROUSSEAU, TJ ;
MCELNAY, JC ;
COLLIER, PS .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1989, 54 (01) :1-13
[7]   PROTEIN-BINDING OF PHENYTOIN AND LIDOCAINE IN PEDIATRIC-PATIENTS WITH TYPE-I DIABETES-MELLITUS [J].
KEARNS, GL ;
KEMP, SF ;
TURLEY, CP ;
NELSON, DL .
DEVELOPMENTAL PHARMACOLOGY AND THERAPEUTICS, 1988, 11 (01) :14-23
[8]   ALTERATION OF PHENYTOIN BINDING BY GLYCOSYLATION OF ALBUMIN IN IDDM [J].
KEMP, SF ;
KEARNS, GL ;
TURLEY, CP .
DIABETES, 1987, 36 (04) :505-509
[9]  
KOSTIC BAP, 1990, PHARMACOTHERAPY, V10, P362
[10]   GLIPIZIDE PHARMACOKINETICS - EFFECTS OF AGE, DIABETES, AND MULTIPLE DOSING [J].
KRADJAN, WA ;
KOBAYASHI, KA ;
BAUER, LA ;
HORN, JR ;
OPHEIM, KE ;
WOOD, FJ .
JOURNAL OF CLINICAL PHARMACOLOGY, 1989, 29 (12) :1121-1127